Traws Pharma Inc. (TRAW)
NASDAQ: TRAW
· Real-Time Price · USD
1.48
-0.14 (-8.64%)
At close: Aug 15, 2025, 12:39 PM
Traws Pharma Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.73M | 57K | 56K | 57K | 57K | 56K | 56K | 57K | 57K | 56K | 56K | 57K | 57K | 56K | 56K | 57K | 57K | 56K |
Cost of Revenue | n/a | 1K | 2K | 2K | 4K | 4K | 4K | 5K | 4K | 3K | 4K | 3K | 4K | 3K | 4K | n/a | n/a | n/a |
Gross Profit | 2.73M | 56K | 54K | 55K | 53K | 52K | 52K | 52K | 53K | 53K | 52K | 54K | 53K | 53K | 52K | n/a | n/a | n/a |
Operating Income | -1.25M | -5.2M | -29.72M | -8.54M | -5.88M | -5.21M | -4.46M | -5.09M | -4.61M | -6.14M | -5.73M | -5.64M | -4.12M | -4.13M | -3.76M | -3.99M | -4.64M | -4.1M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -915K | 21.49M | -29.92M | -8.47M | -123.14M | -4.98M | -4.18M | -4.74M | -4.25M | -5.78M | -5.42M | -5.4M | -4.02M | -4.12M | -3.76M | -3.45M | -4.23M | -4.71M |
Net Income | -915K | 15.08M | 81.93M | -8.47M | -123.14M | -4.98M | -4.18M | -4.74M | -4.25M | -5.78M | -5.42M | -5.4M | -4.02M | -4.12M | -3.76M | -3.45M | -4.23M | -4.71M |
Selling & General & Admin | 1.69M | 2.75M | 3.48M | 3.48M | 1.98M | 3.36M | 2.08M | 2.68M | 2.21M | 2.11M | 2.02M | 2.1M | 2.14M | 2.19M | 2.07M | 2.28M | 2.85M | 2.22M |
Research & Development | 2.29M | 2.5M | 1.86M | 5.11M | 3.96M | 1.91M | 2.43M | 2.46M | 2.45M | 4.08M | 3.77M | 3.59M | 2.03M | 2M | 1.74M | 1.76M | 1.85M | 1.93M |
Other Expenses | n/a | n/a | -24.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.98M | 5.26M | 29.77M | 8.59M | 5.94M | 5.26M | 4.51M | 5.14M | 4.66M | 6.19M | 5.79M | 5.7M | 4.17M | 4.18M | 3.81M | 4.04M | 4.7M | 4.15M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.98M | 5.26M | 29.77M | 8.59M | 5.94M | 5.27M | 4.52M | 5.15M | 4.67M | 6.19M | 5.79M | 5.7M | 4.18M | 4.19M | 3.82M | 4.05M | 4.7M | 4.15M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.82M | 6.97M | 3.65M | 961.53K | 1.01M | 841.74K | 840.14K | 840.12K | 839.19K | 838.41K | 837.04K | 836.62K | 836.16K | 836.16K | 835.82K | 639.17K | 631.23K | 584.64K |
Shares Outstanding (Diluted) | 5.82M | 7.22M | 3.65M | 961.53K | 1.01M | 841.74K | 840.14K | 840.12K | 839.19K | 838.41K | 837.04K | 836.62K | 836.16K | 836.16K | 835.82K | 639.17K | 631.23K | 584.64K |
EPS (Basic) | -0.11 | 2.17 | 22.44 | -8.81 | -121.63 | -5.92 | -4.98 | -5.64 | -5.06 | -6.89 | -6.48 | -6.45 | -4.81 | -4.93 | -4.5 | -5.4 | -6.7 | -8.07 |
EPS (Diluted) | -0.11 | 2.09 | 22.44 | -8.81 | -121.63 | -5.92 | -4.98 | -5.64 | -5.06 | -6.89 | -6.48 | -6.45 | -4.81 | -4.93 | -4.5 | -5.4 | -6.7 | -8.07 |
EBITDA | -914K | 21.49M | -29.92M | -8.47M | -123.14M | -4.98M | -4.18M | -4.73M | -4.25M | -5.77M | -5.42M | -5.39M | -4.02M | -4.12M | -3.76M | -3.45M | -4.23M | -4.71M |
EBIT | -915K | 21.49M | -29.92M | -8.47M | -123.14M | -4.98M | -4.18M | -4.74M | -4.25M | -5.78M | -5.42M | -5.4M | -4.02M | -4.12M | -3.76M | -3.45M | -4.23M | -4.71M |
Depreciation & Amortization | 1K | 1K | 2K | 2K | 4K | 4K | 4K | 5K | 4K | 3K | 4K | 3K | 4K | 3K | 4K | 3K | 4K | 3K |